Literature DB >> 12913102

Glioma therapies: how to tell which work?

James R Perry, J Gregory Cairncross.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12913102     DOI： 10.1200/JCO.2003.05.885

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme.

Authors:  M J Paldino; A Desjardins; H S Friedman; J J Vredenburgh; D P Barboriak
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

2.  Thallium-201 SPECT: the optimal prediction of response in glioma therapy.

Authors:  Maaike J Vos; Johannes Berkhof; Tjeerd J Postma; Otto S Hoekstra; Frederik Barkhof; Jan J Heimans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-29       Impact factor: 9.236

3.  Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.

Authors:  M J Paldino; T Z Wong; D A Reardon; H S Friedman; D P Barboriak
Journal:  Br J Radiol       Date:  2010-10-19       Impact factor: 3.039

4.  Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.

Authors:  Manuel Gómez-Río; Antonio Rodríguez-Fernández; Carlos Ramos-Font; Escarlata López-Ramírez; José Manuel Llamas-Elvira
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-03       Impact factor: 9.236

5.  Evaluation of early imaging response criteria in glioblastoma multiforme.

Authors:  Adam Gladwish; Eng-Siew Koh; Jeremy Hoisak; Gina Lockwood; Barbara-Ann Millar; Warren Mason; Eugene Yu; Normand J Laperriere; Cynthia Ménard
Journal:  Radiat Oncol       Date:  2011-09-23       Impact factor: 3.481

Review 6.  Monitoring radiographic brain tumor progression.

Authors:  Ankit I Mehta; Charles W Kanaly; Allan H Friedman; Darell D Bigner; John H Sampson
Journal:  Toxins (Basel)       Date:  2011-03-15       Impact factor: 4.546

7.  Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.

Authors:  C Walker; B Haylock; D Husband; K A Joyce; D Fildes; M D Jenkinson; T Smith; J Broome; K Kopitzki; D G du Plessis; J Prosser; S Vinjamuri; P C Warnke
Journal:  Br J Cancer       Date:  2006-10-10       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.